Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    granules-india-limited-m-2025-07-07

    Virtual Booth

    Contact Supplier

    Allsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Bristol Myers Squibb

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2BRISTOL MYERS SQUIBB

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    BRISTOL MYERS SQUIBB

    ENASIDENIB MESYLATE

    arrow
    EPS
    Not Confirmed

    BRISTOL MYERS SQUIBB

    U.S.A
    arrow
    EPS
    Not Confirmed

    Patent Expiration Date : 2034-08-01

    ENASIDENIB MESYLATE

    US Patent Number : 10093654

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 209606

    Patent Use Code : U-2087

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-08-01

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    BRISTOL MYERS SQUIBB

    ENASIDENIB MESYLATE

    arrow
    EPS
    Not Confirmed

    BRISTOL MYERS SQUIBB

    U.S.A
    arrow
    EPS
    Not Confirmed

    Patent Expiration Date : 2034-08-01

    ENASIDENIB MESYLATE

    US Patent Number : 10093654

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 209606

    Patent Use Code : U-2087

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-08-01

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF